Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy
NCT01819558
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Chronic Myeloid Leukemia
Myelodysplastic Syndrome
Interventions
BIOLOGICAL:
recwt1-A10+AS01B
Sponsor
Institut Paoli-Calmettes